Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL892819 | 0.79 | ALDH1A1 (0.38) | ALDH1A1KDM4EHPGDPOLBHSD17B10 | |
| Hydrochloric Acid SCHEMBL3306488 | 0.78 | ALDH1A1 (0.41) | ALDH1A1KDM4EHPGDPOLBHSD17B10 | |
| Bromide SCHEMBL3576597 | 0.78 | ALDH1A1 (0.37) | ALDH1A1KDM4EHPGDPOLBHSD17B10 | |
| SCHEMBL11683434 | 0.69 | NOS3 (0.41) | ALDH1A1KDM4EHPGDMEN1MAPT | |
| Pentane SCHEMBL28765480 | 0.69 | ALDH1A1 (0.33) | ALDH1A1KDM4EHPGDPOLBHSD17B10 | |
| SCHEMBL9336565 | 0.69 | — | — | |
| SCHEMBL870972 | 0.68 | — | — | |
| SCHEMBL4554180 | 0.68 | ALDH1A1 (0.36) | ALDH1A1KDM4EHPGDPOLBHSD17B10 | |
| SCHEMBL11326257 | 0.68 | ALDH1A1 (0.43) | ALDH1A1KDM4EHPGDPOLBHSD17B10 | |
| SCHEMBL2230323 | 0.67 | ALDH1A1 (0.30) | ALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0565074-B1 | Process for the preparation of binary sensitizing dyes | EASTMAN KODAK CO (US) | 1999-08-25 | — | — | EP | claimed |
| EP-0565074-A2 | Process for the preparation of binary sensitizing dyes | EASTMAN KODAK COMPANY (US) | 1993-10-13 | — | — | EP | claimed |
| US-4105673-A | PROCESS FOR THE PREPARATION OF LACTONES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1978-08-08 | — | — | US | claimed |
| US-9441179-B2 | Silicon wafer processing solution and silicon wafer processing method | IDEMITSU KOSAN CO., LTD. (JP) | 2016-09-13 | — | — | US | disclosed |
| US-20150045264-A1 | SILICON WAFER PROCESSING SOLUTION AND SILICON WAFER PROCESSING METHOD | IDEMITSU KOSAN CO., LTD. (JP) | 2015-02-12 | — | — | US | disclosed |
| EP-2610896-A1 | SILICON WAFER PROCESSING SOLUTION AND SILICON WAFER PROCESSING METHOD | Idemitsu Kosan Co., Ltd. (JP) | 2013-07-03 | — | — | EP | disclosed |
| US-20130143405-A1 | SILICON WAFER PROCESSING SOLUTION AND SILICON WAFER PROCESSING METHOD | IDEMITSU KOSAN CO., LTD. (JP) | 2013-06-06 | — | — | US | disclosed |
| US-8263779-B2 | Method for separating and purifying α-unsaturated amine compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-09-11 | — | — | US | disclosed |
| US-20110184184-A1 | METHOD FOR SEPARATING AND PURIFYING alpha- UNSATURATED AMINE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-07-28 | — | — | US | disclosed |
| EP-2186802-A1 | METHOD FOR SEPARATING AND PURIFYING ALPHA -UNSATURATED AMINE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2010-05-19 | — | — | EP | disclosed |
| US-7238812-B2 | Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents | MEJI SEIKA KAISHA, LTD. (JP) | 2007-07-03 | — | — | US | disclosed |
| US-4876251-A | ANTIBIOTICS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-10-24 | — | — | US | disclosed |
| US-4851422-A | Antibiotic 2-(3-oxo-2-isoxazolidinyl)-5-oxo-2-tetrahydrofuran-carboxylates | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-07-25 | — | — | US | disclosed |
| EP-0253337-A2 | Tricyclic cepham compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1988-01-20 | — | — | EP | disclosed |
| EP-0249909-A1 | Tricyclic penam compounds, their production and their use | Takeda Chemical Industries, Ltd. (JP) | 1987-12-23 | — | — | EP | disclosed |
| EP-0219923-A1 | Antibiotic derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1987-04-29 | — | — | EP | disclosed |
| CN-86102923-A | The method for preparing antibiotic derivatives | — | 1986-11-12 | — | — | CN | disclosed |
| US-4472389-A | Substituted pyrimidinyl organophosphorus insecticides | UNIROYAL, INC. (US) | 1984-09-18 | — | — | US | disclosed |
| US-4206310-A | Process for the preparation of esters | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1980-06-03 | — | — | US | disclosed |
| US-4105673-A | PROCESS FOR THE PREPARATION OF LACTONES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1978-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110184184-A1 | METHOD FOR SEPARATING AND PURIFYING alpha- UNSATURATED AMINE COMPOUND | HRH3, H1-0, DEGS1 | ALDH1A1 124/4885KDM4E 3523/4885HPGD 1048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.